ZitSticka

It started, improbably, with a golf-ball-sized boil on co-founder Daniel Kaplan's backside. The tar-like ointment he reached for left a dark stain on his skin and a nagging question in his head: why did every spot treatment just sit on the surface, when the trouble was happening underneath it? He took the puzzle to his brother-in-law, who carried a background spanning pharmaceuticals, skincare, and tech, and the two, both longtime acne sufferers themselves, set out to build something that could actually reach a blemish before it crested.

Their answer borrowed from transdermal drug delivery. The debut KILLA patch is studded with dozens of self-dissolving microdarts that gently puncture the skin's barrier to ferry salicylic acid, niacinamide, hyaluronic acid, and peptides into a forming pimple. Crucially, it targeted a different moment than the familiar flat hydrocolloid sticker: not the visible whitehead you can already squeeze, but the deep, tender under-the-skin zit you can feel brewing days early. That single reframe effectively spun up a new category, and KILLA landed on a major magazine's annual best-inventions list; most microdart patches that followed trace their design back to it.

The brand widened from a direct-to-consumer hit into hydrocolloid patches, prep swabs, supplements, and body care, picking up real momentum before the founders relocated abroad, a move that strained leadership and helped tip them toward a sale.

The microdart concept is genuinely clever and fills a narrow gap surface patches can't, intercepting the occasional cyst early. Two honest caveats temper the hype: it's a spot treatment, not a routine for chronic breakouts, and the efficacy figures come from small perception panels rather than rigorous trials, while cheaper imitators now do much the same job.

Sources:[1][2][3]